No­var­tis cuts 275 jobs at Illi­nois site to con­sol­i­date Zol­gens­ma man­u­fac­tur­ing in North Car­oli­na

As No­var­tis con­tin­ues to re­shape it­self, the com­pa­ny is shut­ting the doors to one of its gene ther­a­py man­u­fac­tur­ing sites in the US.

The clo­sure of a site in Lib­er­tyville, IL, a city to the north­east of Chica­go, fol­lows a “com­pre­hen­sive man­u­fac­tur­ing site net­work eval­u­a­tion,” the com­pa­ny said in a state­ment to End­points News.

The de­ci­sion will cause 275 jobs to be axed, but the site is ex­pect­ed to re­main op­er­a­tional through the end of next year, with some ac­tiv­i­ties stop­ping ear­li­er as oth­ers will take time to com­plete. The com­pa­ny will of­fer 90-day no­ti­fi­ca­tions to work­ers along with sev­er­ance pack­ages, out­place­ment sup­port and oth­er ben­e­fits.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN